Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance)

PURPOSE: To determine the frequency and prognostic association of molecular markers by anatomic tumor site in patients with stage III colon carcinomas. EXPERIMENTAL DESIGN: In a randomized trial of adjuvant FOLFOX + cetuximab, BRAF(V600E) and KRAS (exon 2) mutations and DNA mismatch repair (MMR) pro...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Cancer Res
Auteurs principaux: Sinicrope, Frank A., Mahoney, Michelle R., Yoon, Harry H., Smyrk, Thomas C., Thibodeau, Stephen N., Goldberg, Richard M., Nelson, Garth D., Sargent, Daniel J., Alberts, Steven R.
Format: Artigo
Langue:Inglês
Publié: 2015
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4668228/
https://ncbi.nlm.nih.gov/pubmed/26187617
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-15-0527
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires